Armata Pharmaceuticals Commissions Manufacturing Facility in Los Angeles

MT Newswires Live
11/10

Armata Pharmaceuticals (ARMP) said Monday its Good Manufacturing Practice manufacturing facility in Los Angeles, California, has been commissioned.

The company said it has notified the US Food and Drug Administration that production has started, and production runs have been completed with no issues.

The plant allows Armata to make its multi-phage cocktails to support clinical trials, the company said.

Price: 5.92, Change: +0.14, Percent Change: +2.42

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10